Purpose of review We will briefly review the classification of shock and the hallmark features of each subtype. Available modalities for monitoring shock patients will be discussed, along with evidence supporting the use, common pitfalls, and practical considerations of each method.
INTRODUCTION
Shock is an important cause of intensive care unit (ICU) admissions and mortality even with significant advances in medical care. The goal of this review is to provide an updated framework for monitoring these patients. We will briefly summarize the current classification of shock, including distributive, cardiogenic, hypovolemic, and obstructive shock, and review various modalities to diagnosis and monitor shock states. Practical considerations and common pitfalls of cardiopulmonary monitoring in the ICU will be discussed.
SHOCK DEFINITION AND EPIDEMIOLOGY
Shock is a state of cellular hypoxia due to an imbalance of oxygen delivery and oxygen consumption. This is most often due a reduction in relative tissue perfusion with circulatory failure. Cardiac output (CO) and systemic vascular resistance (SVR) proportionally determine blood pressure (BP). In turn, CO is a product of heart rate (HR) and stroke volume (SV). Shock can arise if any of these variables are changed such that CO or SVR is decreased. Shock can also occur if tissue is unable to utilize oxygen appropriately or if oxygen-carrying capacity is not adequate, as can occur with mitochondrial dysfunction or poisoning with carbon monoxide, respectively. Clinically, shock can manifest as a decompensated patient with evidence of end organ failure (e.g., altered mental status, hypotension, or anuria) or more occultly without frank organ dysfunction (e.g., lactic acidosis and mild decreases in BP), referred to as cryptic or compensated shock.
Shock is most commonly classified into four different underlying subtypes with different pathophysiologies: distributive, cardiogenic, hypovolemic, and obstructive. Distinguishing features of these four shock states are described in Table 1 . Mixed shock, with characteristics of more than one of these subtypes, can also occur. The relative frequency of each type of shock at a given institution depends on the population served (e.g., Level I trauma centers will see a higher level of hemorrhagic shock [1] ). A large (n ¼ 1679), multicenter randomized clinical trial (RCT) (the SOAP II trial) found that distributive shock was most common (64%), followed by hypovolemic (16%), cardiogenic (15%), and obstructive (2%) shock among all comers with circulatory failure [2] .
The mortality for each type of shock varies widely. Septic shock is associated with an in-hospital mortality of 30-54% [3
&&
,4], although death rates as low as 19% have been reported in recently completed RCTs [5] . In-hospital mortality from cardiogenic shock can range from 50-80% [6, 7] . Outcomes for distributive shock also vary significantly with cause, with mortality rates as high as 80-90% from traumatic hemorrhage and as low as 19% from shock due to gastrointestinal bleeding [8, 9] . Hypovolemic shock patients tend to do well, with mortality rates under 10% [10] . Obstructive shock includes disparate underlying conditions (e.g., cardiac tamponade and pulmonary embolism), occurs less frequently, and is less well studied, making outcome estimates difficult [11, 12] .
Distributive shock
Distributive shock is defined by severe vasodilatation of the peripheral vasculature and includes septic, anaphylactic, drug or toxin-induced, and neurogenic causes. Sepsis is the most common form and is attributable to dysregulation of the host response to infection and defined most recently as the use of vasopressors in the setting of a rising lactate despite fluid resuscitation [3 && ]. A noninfectious but overtly robust systemic inflammatory response syndrome can mimic septic physiology, as typified by burns or pancreatitis, among other causes. Anaphylaxis is mediated by a severe allergic reaction due to the release of IgE and is usually accompanied by bronchospasm. Neurogenic shock is seen in severe brain or spinal cord injury. These causes lead to increased CO (via increased HR, SV, or both) in response to tissue hypoperfusion from
KEY POINTS
Although the degree and direction of changes in central venous oxygen saturation (ScvO 2 ) correlate with changes in mixed venous oxygen saturation, single values in isolation are unlikely to accurately reflect cardiac output (CO), and treatment aimed at normalizing ScvO 2 does not improve outcomes.
Central venous pressure has historically been used to predict fluid responsiveness; however, current literature does not support its use for this purpose as there appears to be no correlation with circulating blood volume or fluid responsiveness.
Bedside echocardiography should be integrated into care for patients in shock, both for diagnostic purposes and for evaluating potential fluid responsiveness, but can be limited by patient factors and provider skill level.
The pulmonary artery catheter has historically provided the gold standard against which newer monitoring modalities are compared, but its use in shock does not improve outcomes and may increase complications, so it is not recommended for routine use.
Passive leg raising provides a reliable and noninvasive way to assess for volume responsiveness when done correctly.
Emerging minimally or noninvasive CO monitoring devices show empirical promise but require further validation before they can be routinely recommended. extreme vasodilation and increased permeability (low SVR) ( Table 1) .
Cardiogenic shock
This form of shock is defined by a primary intracardiac cause such as arrhythmia, ischemia, valvular dysfunction, or cardiomyopathy leading to decreased CO. Cool extremities due to peripheral vasoconstriction and increased SVR in an attempt to maintain perfusion pressures characterize cardiogenic shock, as well as other findings such as elevated neck veins, rales from pulmonary edema, and leg edema from venous pooling. If the shock is more subacute or cryptic, the extremities may be warm.
Hypovolemic shock
Reduced CO also occurs in hypovolemic shock; however, this is due to reduced intravascular volume and low preload. Major causes include significant hemorrhage or volume depletion due to fluid losses from the kidneys (diuresis or salt wasting), the gastrointestinal system (vomiting or diarrhea), or the skin (severe burns or heat stroke). Both hemorrhagic and nonhemorrhagic shock should lead to compensatory tachycardia and peripheral vasoconstriction to improve CO and perfusion pressure.
Obstructive shock
This is a heterogeneous group of processes, all with low CO due to an obstruction to forward flow. Pulmonary vascular causes that lead to right ventricle (RV) failure and in turn low CO include pulmonary embolism (thrombus, air, foreign body, tumor, or amniotic fluid) or acute or subacute worsening of chronic pulmonary hypertension. Similarly, inadequate filling of the left ventricle from acute tamponade, constrictive pericarditis, restrictive cardiomyopathy, or tension pneumothorax can lead to precipitous falls in CO. Obstructive shock can mirror cardiogenic shock on clinical exam due to peripheral vasoconstriction, increased jugular venous pressure, and tachycardia but is notable for the absence of pulmonary rales.
Shock and its various causes and sub-types may present similarly or occur simultaneously. Diagnosing the underlying pathophysiology is of paramount importance to prevent significant end organ failure and death. Once treatment has begun, monitoring for the improvement of shock as well as for the unmasking of other contributors is critical, as the treatments can vary greatly and run in opposition to each other.
MONITORING

Blood pressure monitoring
BP is perhaps the oldest form of perfusion monitoring outside of the physical exam. It is monitored either statically by sphygmomanometers at the extremities or continuously via arterial catheters. Organ systems each autoregulate their own blood flow, and as such there can be no absolute measurement of BP that ensures or precludes adequate individual organ perfusion, hence the need for other modalities that are used in tandem. Generally, a mean arterial pressure (MAP) less than 65 mmHg is considered pathological, and studies have shown that MAPs above this threshold were not associated with evidence of hypoperfusion or mortality [13] . Lower targets and controlled hypotension (maintaining systolic BP > 70 mmHg) may be preferable in trauma patients with hemorrhagic shock, although this approach remains controversial [14] . A recent multicenter RCT comparing a MAP target of either 80-85 versus 65-70 mmHg showed no difference in survival at 90 days in patients with septic shock, though the higher target led to significantly less use of renal replacement therapy in patients with chronic systemic hypertension but also a higher incidence of atrial fibrillation [15] .
Venous oxygen saturation monitoring
Mixed venous oxygen saturation (MvO 2 or SvO 2 ) is the percentage saturation of hemoglobin in the pulmonary artery measured from the distal tip of a pulmonary artery catheter (PAC). A decreased SvO 2 is a sensitive marker of decreased CO. The SvO 2 drops in cardiogenic shock because the transit time of the blood in the peripheral vasculature is prolonged (CO is measured in liters per minute through a relatively fixed composite distance for that volume of blood to travel). Conversely, in distributive shock, the SvO 2 is usually greater than 70%, due to a failure of the peripheral tissues to extract oxygen and microcirculatory shunt; very high values (>90%) have been associated with worse outcomes [16] . Ventriculoarterial uncoupling with concurrent cardiac dysfunction can also occur in septic shock and lead to low SvO 2 in some cases [17] .
The major downside of SvO 2 is that it can only be obtained by placement of a PAC, the limitations of which are discussed below. Central venous oxygen saturation (ScvO 2 ) can be measured from a venous blood gas drawn from any central venous catheter (preferably in the upper extremities), so it is often used as a practical substitute. Multiple studies have questioned the reliability of ScvO 2 to predict SvO 2 (even allowing for AE10% error) [18] [19] [20] [21] . ScvO 2 is generally regarded as not necessarily equivalent to SvO 2 but potentially useful for trending changes with therapy. The degree and direction of changes in ScvO 2 do correlate with SvO 2 , and a fiberoptic device for continuous ScvO 2 monitoring was developed for this purpose [22] . Although monitoring ScvO 2 may be useful for diagnosing causes of shock and for trending values in individual patient(s), as a treatment target normalizing SvO 2 does not improve morbidity or mortality in critically ill patients [5, 23] . Peripheral venous blood gases have no utility in differentiating shock subtypes.
Measures of central venous pressure
Central venous pressure (CVP) has a normal range of 5-7 mmHg in an adult spontaneously breathing patient while supine. The CVP is elevated in obstructive or cardiogenic shock, whereas it is decreased in septic or hypovolemic shock. CVP can be indirectly measured by the clinical assessment of jugular venous pressure or on ultrasound evaluation of the inferior vena cava (IVC) (see Cardiac echocardiography and ultrasonography). It can be measured directly via a simple manometer attached to a central venous catheter. The transducer should be aligned with the patient's mid chest at the mid-axillary line, at the level of the left atrium. A common pitfall in CVP measurement is not accounting for the effect of positive end expiratory pressure (PEEP) with positive pressure ventilation (Fig. 1) [24] . PEEP may have direct effects on cardiac preload, afterload, and ventricular compliance. PEEP can falsely elevate CVP measurements depending on pulmonary compliance and intrathoracic cavity pressure swings by creating resistance to flow.
Direct measurement of CVP has the benefit of providing 'hard' numbers to compare as the patient's condition changes, but requires a central line. CVP has traditionally been used to guide fluid management, but it is not clear that CVP is a precise or accurate measure in the critically ill or that measuring CVP improves outcomes. A systematic review confirmed that there is no relationship between CVP and circulating blood volume, nor does the CVP predict fluid responsiveness [25] . Because of the lack of data supporting its use combined with the challenges related to assuring the accuracy of CVP in critically ill patients, many physicians argue that CVP should no longer be used to guide management.
Cardiac echocardiography and ultrasonography
Cardiac echocardiography is often useful in the evaluation of patients in shock, providing information about diagnosis (e.g., assessing for valvular disease, changes in wall motion from acute coronary syndrome, acute cor pulmonale in pulmonary embolism, and pericardial effusion with tamponade) and capturing serial changes in contractile function. Several studies have demonstrated the feasibility of this approach, and a recent guideline on the appropriate use of point-of-care ultrasound and echocardiography in critically ill patients has been issued [26, 27, 28, 29 & ]. Echocardiography may be limited by poor image acquisition due to body habitus as well as operator and interpreter experience.
Standard two-dimensional ultrasound can provide real-time assessment of dynamic changes in the IVC, which correlate with direct measurement of CVP and are used clinically to predict SV responsiveness to fluid boluses based on the diameter and collapsibility of the cava for a patient in shock [24, 30] . The use of IVC diameter to predict SV responsiveness has only been validated in patients who are paralyzed and mechanically ventilated [24] . Although this monitoring modality may prove useful in a broader range of shock patients, caution should be used when interpreting results in the setting of chronic severe lung disease and settings in which large intrathoracic and intraabdominal pressure swings occur, for example. The superior vena cava may be similarly assessed by subtracting the diameter at inspiration (minimal width) from the diameter at expiration (maximal width) then dividing by the diameter at expiration [31] . This number is expressed as a collapsibility index, with values greater than 36% correlating to an increased cardiac index following volume expansion [32] . Unfortunately, SVC diameter requires transesophageal echocardiogram, limiting its use, but as the SVC is entirely intrathoracic, it is not confounded by pressures in other spaces. The common femoral vein diameter has been compared with CVP for noninvasive prediction of fluid status as well, but appears less reliable and requires further study [33] . Ultrasound methods are limited by operator experience.
Body habitus and abdominal processes can also compromise image quality.
Pulmonary artery catheter
Also known as the Swan-Ganz catheter, the PAC has had perhaps the most storied journey as a hemodynamic monitoring modality in critical care. This invasive method involves placement of a central venous catheter into the internal jugular vein. As the flow-directed catheter is advanced, waveforms are tracked that reveal the location of the catheter tip as well as the pressures associated with that particular part of the heart or pulmonary vasculature (Fig. 2) . These pressures can then be used to help differentiate between different forms of shock, but require correct interpretation.
A complete set of hemodynamic data includes the direct measurement of CVP (discussed above), right atrial pressure, RV pressures, pulmonary artery pressures, pulmonary artery occlusion or wedge pressure (PAWP), and CO by the thermodilution or Fick method (requiring actual measurement of oxygen consumption and the arteriovenous oxygen concentration difference). Additional parameters such as the indirect Fick CO (based on assumed values of metabolism/oxygen consumption, arterial saturation, and body surface area that are unlikely to be valid in the critically ill), SVR, and pulmonary vascular resistance are calculated. A detailed discussion of PAC measurements and waveform interpretation is beyond the scope of this review; an excellent one is provided by Nishimura and Carbello [34] .
As an estimate of left heart filling pressures, the PAWP can help to differentiate between cardiogenic shock and distributive or hypovolemic shock, as it will be elevated in the former and decreased in the latter (Table 1) . It is notable that the wedge pressure can only be done intermittently and should be measured at end-expiration in zone 3 (pulmonary arterial pressure > pulmonary venous pressure > alveolar pressure) conditions. The measurement of PAWP assumes no obstruction to flow between the left atrium and the left ventricle and normal ventricular compliance (i.e., it is not a measurement of volume) and can be affected by intrathoracic pressure changes, valvular disease, high levels of PEEP, and pulmonary compliance. As with measuring CVP, common mistakes made in PAC measurements and interpretation include not zeroing the transducer, failure to measure pressures correctly at end-expiration, and to account for the effects of positive pressure (the nadir of the waveform in mechanically ventilated patients and the crest of the waveform in spontaneously breathing patients), all of which can lead to erroneous conclusions (Fig. 1) .
A large prospective cohort study found that the use of a PAC to guide shock management was associated with a significant increase in mortality (odds ratio 1.24, 95% confidence interval of 1.03-1.49), increased ICU length of stay, and increased costs [35] . A second large RCT in high-risk surgical patients undergoing urgent or major surgery cared for postoperatively in the ICU demonstrated no benefit of PAC-guided therapy versus standard care, with a higher rate of complications among those who were randomized to PAC [36] . Although these and other studies have failed to demonstrate a benefit of the PAC in populations of critically ill patients [23, [37] [38] [39] , invasive hemodynamic monitoring is the gold standard against which other less-invasive methods are compared. The PAC remains useful in certain patients in whom intravascular volume status and cardiac filling pressures are uncertain, in the setting of mixed shock, and in select patients with preexisting pulmonary vascular or cardiac conditions. Complications include infection of the line, arrhythmias due to irritation of the myocardium, and pulmonary artery rupture. The rate of complications has decreased over time with an adverse event rate of around 4% generally and 1% in experienced centers [40, 41] .
Pulse index continuous cardiac output device
The pulse index continuous cardiac output device (PiCCO) is another form of monitoring that measures CO by integrating trans-cardiopulmonary thermodilution and continuous pulse contour analysis [42] . Measurement of CO by PiCCO has been shown to correlate reasonably well with CO measured by PAC thermodilution, and though PiCCO does not provide waveform or pressure assessments, it can provide continuous values for stroke volume, SVR, and ScvO2 [42, 43] . Arterial and central venous lines are still required with PiCCO, however. One RCT comparing the use of PiCCO versus CVP for therapeutic guidance in patients with septic shock and/or acute respiratory distress syndrome was stopped early for futility as there was no significant difference in mortality, ICU length of stay, vasopressor use, or days free of mechanical ventilation [44] . Another study found a significant decrease in ICU length of stay (3 versus 5 days, p ¼ 0.002) and days on a ventilator (6 versus 11 days, p ¼ 0.004) with PiCCO as compared to CVP-based monitoring in patients with severe thoracic trauma complicated by acute respiratory distress syndrome, suggesting certain subpopulations may derive a benefit [45] . PiCCO can also be used to determine the dynamic arterial elastance (the ratio of pulse pressure variation to respiratory stroke volume variation), which has been shown to be a useful tool to predict blood pressure response when weaning vasopressors or when considering fluid administration [46, 47] . PiCCO provides several other static hemodynamic parameters, including global end diastolic volume of the heart, extravascular lung water, and global ejection fraction, though the utility of these measures are still being investigated [42] . The invasive nature of PiCCO, lack of validation for an appropriate ICU population, and importantly its cost have thus far limited use in the United States.
Pulse pressure variation
Pulse pressure variation (PPV) is another semiinvasive method that has been shown to predict fluid responsiveness. It is calculated by determining the difference between the maximal pulse pressure (pulse pressure ¼ systemic systolic pressuresystemic diastolic pressure) and the minimum pulse pressure divided by the mean pulse pressure over the course of at least three respiratory cycles. A PPV of >13-15% is associated with volume responsiveness in mechanically ventilated patients that are not spontaneously breathing, as shown in multiple studies and systematic reviews [48] [49] [50] . Wide-scale application of PPV is limited by the patient population studied (i.e., mechanically ventilated patients who are not breathing spontaneously and have no cardiac arrhythmia) and by the need for placement of intraarterial catheter in most cases [50] .
Passive leg raising
In light of the lack of evidence supporting the routine use of invasive hemodynamic monitoring in shock patients, there has been increasing interest in the use of less-invasive methods including pointof-care ultrasound (discussed above) and wholly noninvasive methods such as passive leg raising (PLR). PLR is done to determine which patients will have an increase in CO with a fluid challenge. The method involves raising the legs of a supine patient to 45 degrees to increase systemic pressure, which will in turn increase venous return and, in a heart that is still preload-dependent, lead to an increase in CO detected by changes in pulse pressure or caval collapse [51, 52] . This method may be helpful because it is a 'dry run' fluid bolus that may save the patient an unnecessary fluid volume. This method has been investigated in multiple studies and systematic reviews, and it has been found to reliably increase CO (measured by various correlates or directly by thermodiluation) by 10 
Minimally or noninvasive cardiac output monitoring devices
Devices for minimally or noninvasive CO monitoring using arterial pressure tracings and pulse contour analysis (e.g., FloTrac; Edwards Lifesciences, Irvine, California, USA) or chest bioreactance (i.e., NICOM; Cheetah Medical, Inc, Wilmington, Delaware, USA) have been developed. Pulse waveform analysis relies on estimates of SV and detected changes in aortic compliance or impedence and may or may not be directly calibrated. NICOM is based upon the principle of bioreactance measured from electrodes placed on the chest, whereby a change in conductivity of a low magnitude current correlates to a change in intrathoracic blood flow [57, 58] . Early studies have shown promising correlation between these less-invasive technologies and CO measured by thermodilution in critically ill patients; however, further validation is required before widespread use in shock states can be recommended [58] [59] [60] .
CONCLUSION
In summary, shock continues to be an important part of potentially reversible morbidity and mortality in hospitalized patients. The ability to correctly diagnose the type of shock, as well as monitor the efficacy of treatment, is of paramount importance for improving outcomes. Although the pathophysiology for these patients is often complex, the correct use of these modalities (often in combination) can help clarify and potentially simplify the underlying causes of shock. Current literature suggests that there is no one best monitoring modality for shock patients as all may be subject to measurement error and results may be directly affected by patient pathophysiology and interactions with mechanical ventilation. The limitations of each method should be kept in mind as well as the overall clinical picture when determining the reliability of an individual parameter. Local expertise and comfort with specific measures may dictate preference, given the lack of data demonstrating superiority of one method over another. Future advances in shock management are likely to affect the usefulness of the modalities discussed here. Therefore, it is important to stay up to date on emerging technologies while maintaining a grasp on older forms of monitoring in an everevolving field.
